EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 27 March 2025

Blogs

Unmet medical need: How patient perspectives drive meaningful innovation (Guest blog)
20 March 2025

A restrictive definition of unmet need would limit researchers’ capacity to deliver what matters to patients. Read more

Discover EFPIA President's views on how to create a healthier, more competitive Europe

Watch EFPIA President Lars Fruergaard Jørgensen discuss how we can work together to make Europe the leading destination for research, development, and manufacturing of new diagnostics, treatments, and vaccines.

EFPIA Conference 2024 - What cure to boost EU competitiveness
... Read more

IMAGINE a healthier, more competitive Europe: Interview with Lars Fruergaard Jørgensen
... Read more

Events

Unlocking efficiency through reliance: Navigating the EMA post-authorization framework
03 April 2025 (Virtual event)

Register now to join this webinar. Read more

Vaccines & the EU HTA regulation: Why, what and how?
15 April 2025 (Virtual event)

With the EU HTA regulation now in force (January 2025), this session will explore the critical need to account for vaccines... Read more

IHI online event on childhood cancer research tools
24 April 2025 (Virtual event)

Join to discover the results of the ITCC-P4 public-private partnership. Read more

International conference on protein stability – The gap between industry and administration...
13 May 2025 (Södertälje Science Park, Sweden)

The objective of this symposium/conference is to create an arena for discussions on the recent research and industrial... Read more

What we are reading

How can Europe regain its position as the premier location for scientific research, skills...
On 26 March 2025 (Quotidiano Sanità)

The European pharmaceutical industry is at a critical crossroads. As the world evolves, Europe has struggled to equip... Read more

Have your say on the new strategy for European Life Sciences
On 26 March 2025 (European Commission)

The Commission has launched a call for evidence to gather input for the upcoming strategy for European Life Sciences.... Read more

Health is a strategic investment in human capital, not a cost, argues new report
On 21 March 2025 (Euractiv)

Non-communicable diseases are costing the EU billions of euros annually. Increasing investment in detection, diagnosis,... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu